SANA · Sana Biotechnology, Inc.
$3.89
+0.06 (+1.57%)
At close · Sep 2
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.15B
Shares
299.36M
Sana Biotechnology, Inc. Earnings Call Transcripts
Quarterly earnings calls for Sana Biotechnology, Inc. (SANA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-09
Sana Biotechnology, Inc. (SANA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Sana Biotechnology, Inc. (SANA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-08
Sana Biotechnology, Inc. (SANA) Q1 2025 Earnings Call Transcript
Confident tone
Clinical Catalysts and Timelines
Type 1 Diabetes / Hypoimmune Platform
Manufacturing Readiness
Diluted EPS
$-0.21
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 earnings calls
Key facts
CIK
1770121
CUSIP
799566104
13F (30d)
173 filings
172 filers
Visit website
Investor relations